2025-11-30 - Analysis Report
Okay, here's a comprehensive analysis of Chevron Corp (CVX) based on the provided data.

**1) Return Rate Comparison & Analysis**

*   **Company Overview:** Chevron Corp (CVX) is one of the world's leading integrated energy companies involved in virtually every facet of the energy industry.
*   **Cumulative Return (CVX):** 35.99%
*   **Cumulative Return (VOO - S&P 500):** 101.92%
*   **Divergence:** -59.7 (Relative Divergence: 4.7)

**Analysis:** CVX has significantly underperformed the S&P 500 over the period reflected in the cumulative return data. The -59.7% divergence highlights this substantial difference in investment performance. The Relative Divergence of 4.7 suggests that CVX is currently near the bottom of its divergence range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD    | Alpha   | Beta  | Cap(B)  |
|------------|----------|--------|---------|-------|---------|
| 2015-2017  | 33.0%    | 65.9%  | 5.0%    | 0.1   | 252.2   |
| 2016-2018  | 21.0%    | 71.9%  | 6.0%    | 0.2   | 219.2   |
| 2017-2019  | 3.0%     | 71.9%  | -19.0%  | 0.9   | 242.8   |
| 2018-2020  | -10.0%   | 79.6%  | -33.0%  | 0.7   | 170.2   |
| 2019-2021  | 22.0%    | 79.6%  | -25.0%  | 0.6   | 236.4   |
| 2020-2022  | 85.0%    | 83.2%  | 86.0%    | 0.3   | 361.6   |
| 2021-2023  | 49.0%    | 83.2%  | 47.0%    | 0.4   | 300.5   |
| 2022-2024  | -6.0%    | 83.2%  | -26.0%  | 0.2   | 291.8   |
| 2023-2025  | -46.0%   | 74.8%  | -113.0% | 0.6   | 304.5   |

**Analysis:**
*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows fluctuating returns over the periods.  The period of 2020-2022 was a strong performer. The most recent period (2023-2025) shows significant negative growth.
*   **MDD:** Maximum Drawdown (MDD) is consistently high, indicating significant potential downside risk.
*   **Alpha:** Alpha measures the stock's performance relative to its benchmark.  The negative Alpha values for several periods (especially 2023-2025) indicate underperformance relative to the benchmark. The 2020-2022 period shows strong positive alpha, suggesting outperformance.
*   **Beta:** Beta measures the stock's volatility relative to the market. The Beta values fluctuate, suggesting that CVX's volatility relative to the market has varied over time.  Beta values generally are relatively low, indicating lower volatility than the overall market.
*   **Cap(B):** Market capitalization, shown in billions, indicates the size of the company.

**2) Recent Stock Price Fluctuations**

*   **Close:** 151.13
*   **Last-market:** {'price': 151.13, 'previousClose': 149.51, 'change': 1.08}
*   **5-day SMA:** 149.78
*   **20-day SMA:** 153.1805
*   **60-day SMA:** 154.5963

**Analysis:**  The stock price closed at 151.13, showing a small increase from the previous close.  The 5-day SMA is below both the 20-day and 60-day SMAs, suggesting a short-term downward trend.  The 20-day SMA is below the 60-day SMA, reinforcing a potential medium-term downward trend.

**3) RSI, PPO, and Other Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment)
*   **RSI:** 40.34
*   **PPO:** -0.3026
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (12 shares - Safe - MRI:0.80) Dividend_1.71 (Cash Ratio: 0% on 2025-11-18)
*   **Recent (20 days) relative divergence change:** -1.1 (Short-term decline)
*   **Expected Return (%):** 209.1%

**Analysis:**

*   **MRI:** A medium investment recommendation indicates a moderate level of risk associated with investing in CVX.
*   **RSI:** An RSI of 40.34 suggests that the stock is not overbought or oversold.
*   **PPO:** A negative PPO indicates that the short-term moving average is below the long-term moving average, suggesting a downward trend.
*   **Hybrid Signal:** The Hybrid Signal suggests buying 90% of available cash with a safety rating.
*   **Relative Divergence Change:** The short-term decline in relative divergence (-1.1) aligns with the downward trend suggested by the SMAs and PPO.
*   **Expected Return:** The high expected return (209.1%) is a significant factor, suggesting potential long-term upside.

**4) Recent News & Significant Events**

*   The news articles present a mixed picture:
    *   Some articles recommend CVX as a buy, highlighting its dividend yield and potential value.
    *   Other articles point out that CVX is underperforming the S&P 500.
    *   One article mentions Warren Buffett's holdings, potentially lending credibility to CVX as a long-term investment.
    *   Another article reports Mackenzie Financial Corp sold shares of CVX.

**Analysis:** The news sentiment is somewhat neutral to slightly positive, but the underperformance relative to the S&P 500 is a recurring theme.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.15)
*   **Target Price:** 172.80 (Avg) / 204.00 (High) / 124.00 (Low)
*   **Recent Rating Changes:** No specific changes are listed.

**Analysis:** Analyst consensus leans towards a "Buy" rating with a significant potential upside based on the average target price. However, there's a wide range in target prices, indicating uncertainty among analysts.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출          |
|------------|------|---------------|
| 2025-11-06 | 1.83 | 48.17 B$      |
| 2025-08-07 | 1.45 | 44.38 B$      |
| 2025-05-08 | 2.01 | 46.10 B$      |
| 2024-11-07 | 2.49 | 48.93 B$      |
| 2025-11-06 | 2.49 | 48.93 B$      |

**Analysis:**
*   The most recent EPS (1.83) is lower than the EPS from a year ago (2.49), suggesting a decline in profitability.
*   Revenue has fluctuated but generally remains within a similar range.
*   Overall, the earnings data suggests a recent weakening in performance compared to the previous year.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $48.17B    | 31.12%        |
| 2025-06-30   | $44.38B    | 29.69%        |
| 2025-03-31   | $46.10B    | 29.00%        |
| 2024-12-31   | $48.33B    | 27.34%        |
| 2024-09-30   | $48.93B    | 29.15%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE      |
|--------------|-------------|----------|
| 2025-09-30   | $189.84B    | 1.86%    |
| 2025-06-30   | $146.42B    | 1.70%    |
| 2025-03-31   | $149.24B    | 2.35%    |
| 2024-12-31   | $152.32B    | 2.13%    |
| 2024-09-30   | $156.20B    | 2.87%    |

**Analysis:**
*   **Revenue:** Revenue has been relatively stable.
*   **Profit Margin:** Profit margins have improved in the most recent quarter.
*   **Equity:** Equity has increased in the most recent quarter.
*   **ROE:** ROE has decreased in the most recent quarter compared to previous year quarter.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** CVX has significantly underperformed the S&P 500, indicated by the substantial divergence in cumulative returns.
*   **Mixed Indicators:** Technical indicators present a mixed picture. SMAs and PPO suggest a short-term downward trend, while the RSI is neutral. The MRI suggests medium investment risk, and the hybrid signal advises a 90% buy with cash.
*   **News Sentiment:** News sentiment is mixed, with some articles recommending CVX while others highlight its underperformance.
*   **Analyst Consensus:** Analyst consensus is a "Buy" with a significant potential upside based on target prices, but there is a wide range of opinions.
*   **Earnings:** Recent earnings data suggests a decline in profitability and decreased ROE compared to the previous year. However, equity has increased recently and profit margins have improved.
*   **Financial Health:** Overall, the company appears financially sound, but earnings and profitability have shown recent signs of decline.

**Overall Recommendation:**

Based on this analysis, a cautious approach is warranted. While the high expected return is tempting, the underperformance relative to the S&P 500 and the recent decline in earnings are concerning. The analyst consensus and target prices suggest potential upside, but the wide range in target prices indicates uncertainty. Before investing, it's important to weigh the potential risks and rewards. Monitor the company's earnings and revenue trends, as well as any significant news or events that could impact its performance.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.